Market Overview

Research and Markets: Herpes Infections - Pipeline Review: Latest updates and review of key players


Research and Markets ( has announced the addition of Global Markets Direct's new report "Herpes Infections - Pipeline Review, H2 2012" to their offering.

This report provides information on the therapeutic development for Herpes Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Herpes Infections.

Herpes Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.


- A snapshot of the global therapeutic scenario for Herpes Infections.

- A review of the Herpes Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Herpes Infections pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Herpes Infections.

- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.

- Devise corrective measures for pipeline projects by understanding Herpes Infections pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.

Companies Involved in Herpes Infections Therapeutics Development:

- Vical Incorporated

- GlaxoSmithKline plc

- Antigenics, Inc.

- GenVec, Inc.

- Merck & Co., Inc.

- Piramal Healthcare Limited

- Novartis AG

- Astellas Pharma Inc.

- Alfacell Corporation

- CEL-SCI Corporation

- Intercell AG

- Mymetics Corporation

- NanoViricides, Inc.

- Nutra Pharma Corporation

- Peregrine Pharmaceuticals, Inc.

- CytoGenix, Inc.

- Alnylam Pharmaceuticals, Inc

- Flamel Technologies S.A.

- Starpharma Holdings Limited

- Summit Corporation plc

- BioAlliance Pharma SA

- Clavis Pharma ASA

- Oryzon

- Functional Genetics, Inc.

- Colby Pharmaceutical Company

- Nutri Pharma ASA

- Vironova AB

- Altor BioScience Corporation

- Osel Inc.

- AiCuris GmbH & Co. KG

- Cell Medica Limited

- AlphaVax, Inc.

- Nitric Biotherapeutics, Inc.

- Romark Laboratories, L.C.

- Chimerix, Inc.

- aRigen Pharmaceuticals, Inc.

- Lumavita AG

- Theraclone Sciences, Inc.

- Sinovac Biotech Ltd.

- Wittycell S.A.S.

- Microbiotix, Inc.

- NanoBio Corporation

- PharmaNova Inc.

- Immune Design Inc.

- Redox Pharmaceutical Corporation

- PepTcell Limited

- 4-Antibody AG

- Arisyn Therapeutics Inc.

- Epiphany Biosciences, Inc.

- Cannabis Science, Inc.

- Synergy Pharmaceuticals, Inc.

- Genocea Biosciences, Inc.

- Variation Biotechnologies, Inc.

- AIMM Therapeutics B.V.

- China National Pharmaceutical Group Corporation

- Trellis Bioscience, Inc.

- Vakzine Projekt Management GmbH

- Spider Biotech S.r.l.

- Kala Pharmaceuticals

- Beech Tree Labs, Inc.

- FunZyme BioTechnologies S.A.

For more information visit

Source: Global Markets Direct

Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Infectious Diseases

View Comments and Join the Discussion!

Partner Center